Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_assertion type Assertion NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_head.
- NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_assertion description "[We therefore aimed to study receptor conversion for estrogen receptor alpha (ER?), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) in a large group of distant (non-bone) breast cancer metastases by re-staining all primary tumors and metastases with current optimal immunohistochemical and in situ hybridization methods on full sections.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_provenance.
- NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_assertion evidence source_evidence_literature NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_provenance.
- NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_assertion SIO_000772 20863372 NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_provenance.
- NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_assertion wasDerivedFrom befree-20140225 NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_provenance.
- NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_assertion wasGeneratedBy ECO_0000203 NP238645.RAL_Ocevd1lEkyRAFcJkwEPG8htRQNLpaAEdL_a009R0c130_provenance.